TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alibaba Health Information Technology ( (HK:0241) ) has provided an update.
Alibaba Health Information Technology Limited reported a significant increase in revenue and net profit for the six months ending September 30, 2025, with revenue growing by 17% and net profit by 64.7%. The company has seen growth in its Tmall Healthcare Platform’s consumer base and average revenue per user, driven by strategic partnerships and supply-side optimizations. Alibaba Health is also investing in AI to strengthen its market position and contribute to the healthcare industry’s innovation, aligning with China’s national policy initiatives for high-quality development.
The most recent analyst rating on (HK:0241) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare industry, focusing on pharmaceutical direct sales and healthcare platforms. The company is a flagship healthcare platform of Alibaba Group, emphasizing AI applications and tools development to enhance healthcare services.
Average Trading Volume: 112,592,870
Technical Sentiment Signal: Hold
Current Market Cap: HK$92.36B
For an in-depth examination of 0241 stock, go to TipRanks’ Overview page.